These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17632592

  • 1. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB, Chung AW, Zhang H, Laher I, van Breemen C.
    Can J Physiol Pharmacol; 2007 May; 85(5):562-7. PubMed ID: 17632592
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
    Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT.
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice.
    Guo Y, Zhang C, Du X, Nair U, Yoo TJ.
    Hear Res; 2005 Oct; 208(1-2):54-67. PubMed ID: 16051453
    [Abstract] [Full Text] [Related]

  • 8. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.
    van Weel V, de Vries M, Voshol PJ, Verloop RE, Eilers PH, van Hinsbergh VW, van Bockel JH, Quax PH.
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1383-90. PubMed ID: 16574899
    [Abstract] [Full Text] [Related]

  • 9. NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
    Nevelsteen I, Van den Bergh A, Van der Mieren G, Vanderper A, Mubagwa K, Bult H, Herijgers P.
    J Vasc Res; 2013 Jun; 50(6):486-97. PubMed ID: 24192582
    [Abstract] [Full Text] [Related]

  • 10. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R, Watada H.
    Biochem Biophys Res Commun; 2006 Jun 30; 345(2):688-93. PubMed ID: 16696939
    [Abstract] [Full Text] [Related]

  • 11. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction.
    Oomen PH, Kant GD, Dullaart RP, Reitsma WD, Smit AJ.
    Microvasc Res; 2002 Jan 30; 63(1):1-9. PubMed ID: 11749067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P.
    Diabetes Metab; 2001 Sep 30; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [Abstract] [Full Text] [Related]

  • 14. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M, D'Aleo V, Lupi R, Paolini M, Soleti A, Marchetti P, Masiello P.
    Pancreas; 2007 Nov 30; 35(4):e10-7. PubMed ID: 18090226
    [Abstract] [Full Text] [Related]

  • 15. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W, Tan CY, Ang L, Sallam N, Granville DJ, Wright JM, Laher I.
    J Physiol Sci; 2008 Dec 30; 58(6):405-11. PubMed ID: 18845058
    [Abstract] [Full Text] [Related]

  • 16. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG.
    J Diabetes Complications; 2007 Dec 30; 21(3):149-57. PubMed ID: 17493547
    [Abstract] [Full Text] [Related]

  • 17. The endothelial dysfunction in diabetes mellitus.
    Pănuş C, Moţa M, Vladu D, Vanghelie L, Răducanu CL.
    Rom J Intern Med; 2003 Dec 30; 41(1):27-33. PubMed ID: 15529582
    [Abstract] [Full Text] [Related]

  • 18. Endothelial dysfunction in insulin resistance and type 2 diabetes.
    Jansson PA.
    J Intern Med; 2007 Aug 30; 262(2):173-83. PubMed ID: 17645585
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C, King GL.
    Nat Clin Pract Endocrinol Metab; 2007 Jan 30; 3(1):46-56. PubMed ID: 17179929
    [Abstract] [Full Text] [Related]

  • 20. Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes.
    Lee YA, Cho EJ, Yokozawa T.
    J Agric Food Chem; 2008 Sep 10; 56(17):7781-9. PubMed ID: 18690694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.